Incidence of Acute Cystoid Macular Edema After Starting a Prostaglandin Analog Compared With Other Classes of Glaucoma Medications
-
Published:2024-08
Issue:
Volume:
Page:
-
ISSN:2589-4196
-
Container-title:Ophthalmology Glaucoma
-
language:en
-
Short-container-title:Ophthalmology Glaucoma
Author:
Zhou YujiaORCID, Bicket Amanda K., Marwah Shikha, Stein Joshua D., Kishor Krishna S.ORCID, Pershing Suzann, Wang Sophia Y., Amin Sejal, Srikumaran Divya, Woreta Fasika, Schultz Jeffrey S., Shrivastava Anurag, Ahmad Baseer, Lee Rachel, Bryar Paul, French Dustin, Ramachandran Rajeev, Vanderbeek Brian L., Deiner Michael, Sun Catherine, Patnaik Jenna, Subramanian Prem, Munir Saleha, Munir Wuqaas, Stein Joshua D., De Lott Lindsey, Feldman Robert, Stagg Brian C., Wirostko Barbara, McMillian Brian, Liu Ji, Sarrapour Soshian
Reference29 articles.
1. Xalatan. [package insert]. Puurs, Belgium: Pfizer Manufacturing Belgium NV; 2022 2. FDA Adverse Event Reporting System (FAERS) Public Dashboard. https://fis.fda.gov/sense/app/95239e26-e0be-42d9-a960-9a5f7f1c25ee/sheet/7a47a261-d58b-4203-a8aa-6d3021737452/state/analysis; accessed April 27, 2024 3. The Effect of Latanaprost on Intraocular Inflammation and Macular Edema;Razeghinejad;Ocul Immunol Inflamm,2019 4. Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: Mechanism, diagnosis, and management;Holló;Surv Ophthalmol,2020 5. Cystoid macular edema associated with preservative-free latanoprost after uncomplicated cataract surgery: case report and review of the literature;Makri;BMC Res Notes,2017
|
|